<DOC>
	<DOCNO>NCT01242241</DOCNO>
	<brief_summary>Obesity child , adult , rapidly become public health concern . Studies adult show obesity , consider disease state , modifier effect drug body well body handle drug.The anesthetic management obese child pose variety significant challenge include determination appropriate dose anesthetic intravenous agent . Dosing drug calculate base effective dose 50 % patient practical require information effective dose 95 % ( ED95 % ) patient . The aim study determine effective dose 95 % patient ( child ) . The hypothesis ED95 propofol obese child higher non-obese child .</brief_summary>
	<brief_title>Propofol Obese Children</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<criteria>1 . Children age 3 17 year fall category nonobese ( BMI percentile 2584th percentile ) obese ( &gt; 95th percentile ) 2 . American Society Anesthesiology ( ASA ) classification 1 2 1 . Patients classify ASA ( American Society Anesthesiology ) Class 3 great . 2 . Patients document kidney liver disease present open surgery liver kidney . 3 . Patients NOT receive propofol induction part anesthetic regimen . 4 . Patients currently anticonvulsant medication receive drug sedative effect . 5 . Patients currently treat attention deficit disorder . 6 . Patients diagnosed failure thrive BMI le 25th percentile . 7 . Patients hemodynamically unstable . 8 . Patients egg allergy . 9 . Patients low level albumin</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Propofol</keyword>
	<keyword>Childhood obesity</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>